Content about Antifungals

December 17, 2013

Greenstone has launched a version of a drug used to treat fungal infections, the company said.

PEAPACK, N.J. — Greenstone has launched a version of a drug used to treat fungal infections, the company said.

Greenstone, the generics subsidiary of Pfizer, announced the introduction of voriconazole for oral suspension, an authorized generic version of Pfizer's Vfend. Authorized generics are branded drugs sold at a discount under their generic names.

Greenstone is selling the drug in the 40 mg-per-milliliter strength. Vfend had sales of about $17.1 million during the 12-month period that ended in June, according to IMS Health.

 

November 26, 2013

The Food and Drug Administration has approved a new tablet form of an antifungal drug made by Merck, the company said Tuesday.

WHITEHOUSE STATION, N.J. — The Food and Drug Administration has approved a new tablet form of an antifungal drug made by Merck, the company said Tuesday.

Merck announced the FDA approval of Noxafil (posaconazole) 100-mg delayed release tablets. The company also markets a 40-mg-per-milliliter oral suspension form of the drug. The new tablet formulation is designed to be taken in two 300-mg doses on the first day, followed by a 300-mg dose once per day.

November 15, 2013

The Food and Drug Administration has approved a new drug for fungal infections of the skin made by Valeant Pharmaceuticals International, the drug maker said Friday.

LAVAL, Quebec — The Food and Drug Administration has approved a new drug for fungal infections of the skin made by Valeant Pharmaceuticals International, the drug maker said Friday.

The company announced the FDA approval of Luzu (luliconazole) cream in the 1% strength for treatment of athlete's foot, jock itch and ringworm in adults.

September 30, 2013

Mylan has launched the first generic version of a drug used to treat fungal infections, the company said Monday.

PITTSBURGH — Mylan has launched the first generic version of a drug used to treat fungal infections, the company said Monday.

The drug maker announced the launch of voriconazole for oral suspension in the 40-mg-per-mL strength. The drug is the first generic version of Pfizer's Vfend, and as the first company to receive approval for a generic version, Mylan has 180 days in which to compete exclusively against Pfizer's product. The drug is used to treat invasive fungal infections.

September 9, 2013

Procter & Gamble is working to eliminate two chemicals — triclosan and diethyl phthalate — from its products by 2014, the manufacturer has stated on its website.

CINCINNATI — Procter & Gamble is working to eliminate two chemicals — triclosan and diethyl phthalate — from its products by 2014, the manufacturer has stated on its website.

According to P&G, triclosan is an antimicrobal ingredient that slows or stops the growth of germs, such as bacteria and mildew. P&G stated that it only uses triclosan in antibacterial dish soap, professional hand soap and a few personal care products.

August 6, 2013

Actavis has acquired global rights to a drug made by a Spanish company for fungal infections of the vagina, the companies said Tuesday.

PARSIPPANY, N.J. — Actavis has acquired global rights to a drug made by a Spanish company for fungal infections of the vagina, the companies said Tuesday.

Actavis and Palau Pharma announced that Actavis Specialty Brands had acquired right's to albaconazole, an orally administered antifungal for vulvo-vaginal candidiasis, onychomycosis and others. The drug, which Palau discovered, is currently in phase-2 clinical trials, and Actavis foresees a potential U.S. commercial launch of the drug in 2017.

July 15, 2013

The National Advertising Division referred to the Federal Trade Commission advertising claims made by Fiore RX, for its Antifungal Nail Lacquer after the company failed to respond to an NAD inquiry.

NEW YORK — The National Advertising Division last week referred to the Federal Trade Commission advertising claims made by Fiore RX, for its Antifungal Nail Lacquer after the company failed to respond to an NAD inquiry.

The company purported its "FDA-registered" ingredients undecylenic Acid and propolis "is the best antifungal nail polish for preventing toenail and finger nail fungus (onychomycosis)."

June 26, 2013

The Food and Drug Administration has approved a drug made by Astellas Pharma for treating fungal infections in children.

NORTHBROOK, Ill. — The Food and Drug Administration has approved a drug made by Astellas Pharma for treating fungal infections in children.

July 27, 2012

Mylan has launched a generic drug for treating fungal infections, the drug maker said Friday.

PITTSBURGH — Mylan has launched a generic drug for treating fungal infections, the drug maker said Friday.

Mylan announced the launch of itraconazole capsules in the 100-mg strength. The drug is a generic version of Johnson & Johnson's Sporanox, which is used to treat fungal infections that begin in the lungs blatsomycosis, histoplasmosis and aspergillosis in patients who are intolerant of or refractory to amphotericin B therapy. The drug also is used to treat fungal infections in the toenails and fingernails in patients without compromised immune systems.

May 31, 2012

MarcasUSA on Thursday announced the U.S. debut of Conazol, a leading over-the-counter athlete's foot treatment in Mexico.

EL SEGUNDO, Calif. — MarcasUSA on Thursday announced the U.S. debut of Conazol, a leading over-the-counter athlete's foot treatment in Mexico.

The brand is expanding its U.S. distribution and can be found at such retailers as Walmart and Target in key U.S. Hispanic markets, such as Los Angeles, Houston, Dallas and Chicago, the company said.

May 23, 2012

The Food and Drug Administration has approved a generic treatment made by Perrigo for fungal infections of the vagina, the company said.

ALLEGAN, Mich. — The Food and Drug Administration has approved a generic treatment made by Perrigo for fungal infections of the vagina, the company said.

Perrigo announced the approval of butoconazole nitrate 2% vaginal cream, a generic version of KV Pharmaceutical's Gynazole-1, used to treat vulvovaginal candidiasis, an infection caused by Candida fungus. KV voluntarily discontinued selling the drug in January 2009 due to manufacturing problems.

December 19, 2011

The Food and Drug Administration has approved a drug made by Sandoz for treating yeast and other fungal infections.

PRINCETON, N.J. — The Food and Drug Administration has approved a drug made by Sandoz for treating yeast and other fungal infections.

Sandoz announced Monday the approval of voriconazole tablets in the 50-mg and 200-mg strengths, a generic version of Pfizer's Vfend.

Branded and generic versions of the drug had sales of about $189 million during the 12-month period ended in October, according to IMS Health.

 

August 30, 2011

The Food and Drug Administration has approved a treatment for dermatitis made by Perrigo under a collaboration with Chicago-based Cobrek Pharmaceutical.

ALLEGAN, Mich. — The Food and Drug Administration has approved a treatment for dermatitis made by Perrigo under a collaboration with Chicago-based Cobrek Pharmaceutical.

The drug maker said Tuesday that the FDA approved ketoconazole foam in the 2% strength. The drug is a generic version of Stiefel Labs' Extina, a topical drug used to treat seborrheic dermatitis in patients ages 12 years and older with healthy immune systems.

Extina has annual sales of about $10 million, according to Perrigo.

August 19, 2011

NexMed USA on Thursday received clearance from the Food and Drug Administration to market the company's first over-the-counter antifungal drug, Tolnaftate-D.

SAN DIEGO — NexMed USA on Thursday received clearance from the Food and Drug Administration to market the company's first over-the-counter antifungal drug, Tolnaftate-D.

NexMed USA's Tolnaftate-D incorporates NexACT, a proprietary drug delivery technology that transiently loosens the tight junction between the cells of the sealed skin to allow more permeation.

March 21, 2011

Generic drug maker Hi-Tech Pharmacal has acquired the rights to a drug for mouth infections, the company said Monday.

AMITYVILLE, N.Y. — Generic drug maker Hi-Tech Pharmacal has acquired the rights to a drug for mouth infections, the company said Monday.

Hi-Tech said it acquired nystatin oral suspension from Bausch & Lomb for an undisclosed sum. The drug is used to treat candidiasis, a fungal infection, in the mouth.

The market for the drug is $23 million, according to IMS Health.

February 15, 2011

Mylan has launched a generic drug for fungal infections, the company said Tuesday.

PITTSBURGH — Mylan has launched a generic drug for fungal infections, the company said Tuesday.

Mylan announced the launch, through subsidiary Mylan Pharmaceuticals, of voriconazole tablets in the 50-mg and 200-mg strengths. The drug is a triazole antifungal agent.

The tablets are a generic version of Pfizer’s Vfend, which had sales of $186 million in 2010, according to IMS Health. Mylan launched its version of the drug under a settlement with Pfizer.

June 9, 2010

The Food and Drug Administration has approved Breckenridge Pharmaceutical’s generic version of a fungal infection...

June 2, 2010

Perrigo on Thursday announced that it has received final approval from the Food and Drug...

January 26, 2010

Procter & Gamble's Head & Shoulders brand is stepping into the men's grooming segment with...

September 19, 2007

Teva is introducing its generic to the Sanofi-Aventis anti-fungal medication Penlac nail lacquer....